Crossmark

Development of a biotechnological process for the production of recombinant canine interferon-alpha using the baculovirus-insect cell and larvae system

Crossref DOI link: https://doi.org/10.1007/s10529-025-03644-x

Published Online: 2025-09-11

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rodriguez, Maria S.

Smith, Ignacio

Villaverde, Marcela S.

Birenbaum, Joaquin M.

Poodts, Joaquin

Wolman, Federico J.

Targovnik, Alexandra M.

Miranda, Maria V. https://orcid.org/0000-0003-0862-2122
Funding

Funding for this research was provided by:

UBA (UBACYT 2020)

conicet (PIP 2021)
License Information

Text and Data Mining valid from 2025-09-11

Version of Record valid from 2025-09-11
More Information

Article History

Received: 13 June 2025

Revised: 22 August 2025

Accepted: 1 September 2025

First Online: 11 September 2025

Declarations

:

: The authors declare that they have no conflict of interest in the publication.

Document is current

Any future updates will be listed below